Fulminant myocarditis after the second dose of COVID-19 mRNA vaccination.

Akihiro OkaYuya SudoToru MiyoshiMasatomo OzakiYuta KimuraWataru TakagiSatoko UgawaTomoaki OkadaKazumasa NosakaMasayuki Doi

Published in: Clinical case reports (2022)

Myocarditis is an adverse event associated with coronavirus disease 2019 (COVID-19) mRNA vaccination. A 50-year-old man presented with dyspnea and resting chest pain after receiving the second dose of the COVID-19 mRNA vaccine and developed cardiogenic shock. Fulminant myocarditis was diagnosed by endomyocardial biopsy and treated with intravenous corticosteroids.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
binding protein
heart rate
high dose
heart rate variability
liver failure
low dose
hepatitis b virus
drug induced